Breaking News
February 25, 2018 - New staining method helps analyze 3D tissue samples using Nano-CT system
February 25, 2018 - Rare immune cell may prove to be potent weapon in fighting against cancer
February 25, 2018 - Connection between heart disease and cancer treatment
February 25, 2018 - Longer Endocrine Tx Better in Prostate Cancer
February 25, 2018 - Gene therapy restores normal blood glucose levels in mice with type 1 diabetes
February 25, 2018 - Desymmetrization paves way for new bioactive compounds
February 25, 2018 - Study finds underutilization of less expensive, post-acute care options for older adults
February 25, 2018 - UNIST researchers introduce new biosensing contact lens for diabetics
February 25, 2018 - Research consortium develops first 3D computer model of metabolic processes
February 25, 2018 - Adding hope to health messages may help promote preventative actions, researchers say
February 25, 2018 - Sudden Hearing Loss Recovery Hampered by Metabolic Syndrome
February 25, 2018 - First human trial of potentially game-changing diabetes treatment set to commence
February 25, 2018 - Child’s snacking patterns could be linked to genetics, study finds
February 25, 2018 - Patients with terminal cancer may be less competent to make big decisions
February 25, 2018 - Study highlights risks involved in short-term use of PICCs
February 25, 2018 - Study shows no increase in complications with ‘ad lib’ oral intake during labor
February 25, 2018 - Although Plaquenil (Hydroxychloroquine) Eases Rheumatoid Arthritis Pain it Won’t Help ‘Regular’ Arthritis
February 25, 2018 - Methotrexate May Help in Chronic Viral Arthritis
February 25, 2018 - Lack of guidance may delay a child’s first trip to the dentist
February 25, 2018 - Study shows cost-effectiveness of screening for fracture risk in older postmenopausal women
February 24, 2018 - Younger women with SCAD may benefit most from conservative treatment
February 24, 2018 - Blood Test for Concussion OK’d
February 24, 2018 - What are symptoms of an alcohol use disorder? – Rethinking Drinking
February 24, 2018 - Streamlined, cost-cutting post-treatment dental advice via iPad
February 24, 2018 - Researchers discover new regulator of the immune system
February 24, 2018 - Reducing red tape for traveling nurses
February 24, 2018 - Study supports benefits of meditation in control of attention and emotions
February 24, 2018 - Flu Vax Data ‘Only Tell Half the Story’
February 24, 2018 - Calculators – Rethinking Drinking – NIAAA
February 24, 2018 - From stem cells to a functional heart—the role of the Mesp1 gene
February 24, 2018 - Non-adherence to sleep apnea treatment linked to increased hospital readmissions
February 24, 2018 - Exercise-related posts influence health of social media pals
February 24, 2018 - Will Device Meetings in Europe Suffer Under New Ethics Rule?
February 24, 2018 - Nonstatin drug use increases by 124% in U.S., related expenditures triple
February 24, 2018 - Annual foot screening could help spot heart irregularities in people with diabetes
February 24, 2018 - Researchers developing rapid saliva test to detect Zika virus
February 24, 2018 - For Older Men, Even Light Exercise Helps
February 24, 2018 - Healthy Strategies to Beat Stress
February 24, 2018 - Cancer killing clue could lead to safer and more powerful immunotherapies
February 24, 2018 - Repeated sick days do not affect children’s learning ability, study shows
February 24, 2018 - New two-child policy in China could negatively affect women’s status and gender equality
February 24, 2018 - New research project to determine why mine dust-related lung diseases are on the rise
February 24, 2018 - A Tribute to Dr. Ray Lipicky: The Man Who Transformed Cardiology
February 24, 2018 - ClinicalTrials.gov: Child, Foster
February 24, 2018 - Study shows age doesn’t affect survival in patients with non-Hodgkin lymphoma after HCT
February 24, 2018 - Researchers explore how evolutionary processes guide pathways of cells
February 24, 2018 - Discovery may result in new medication to build stronger muscles in old age
February 24, 2018 - New study identifies possible target for treatment of dangerous allergic reactions
February 24, 2018 - Targeted vaccination can be successful in containing epidemic outbreaks
February 24, 2018 - Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
February 24, 2018 - ‘The Best Deals of Any Payer’: What We Heard This Week
February 24, 2018 - Blood and urine tests developed to indicate autism in children
February 24, 2018 - New low-cost microfluidic device brings single-cell technology to bedside
February 24, 2018 - Covestro and Pittsburgh Penguins announce multi-year unique partnership
February 24, 2018 - Children from low-income areas have poor outcomes after heart surgery, study finds
February 24, 2018 - Some genes can drive both metastasis and initial stages of tumor growth
February 24, 2018 - Visaris Americas announces installation of fully robotic Vision C digital X-ray suite at OGHS
February 24, 2018 - New discovery could accelerate clinical translation of stem cell-based therapies
February 24, 2018 - Respiratory disease patients with arthritis struggle to use complex inhalers
February 24, 2018 - FDA Alert: Labetalol Hydrochloride Injection by Hospira: Recall
February 24, 2018 - Flu, Tdap Vax Safe for Babies 6 Months Later
February 24, 2018 - Adults with autism show a diminished brain response to hearing their own name
February 24, 2018 - Study provides insight into neurobiology of dying
February 24, 2018 - Study finds tobacco smoke exposure among most adolescents in economically disadvantaged population
February 24, 2018 - U.S. clinical sites evaluating antibody-based therapies to prevent two common bacterial infections
February 24, 2018 - UCLA researchers use fluorescent colored proteins to trace origin of heart cells
February 24, 2018 - UC Riverside researchers discover way to halt cancer metastasis
February 24, 2018 - Home Routines Can Boost a Child’s Readiness for School
February 24, 2018 - FDA Investigating Misuse, Abuse of Gabapentinoids
February 24, 2018 - Scientists find key proteins control risk of osteoarthritis during aging
February 24, 2018 - Izon announce the launch of the qEV2 and qEV10 Exosome Isolation columns
February 24, 2018 - New CSIRO technology can create clean drinking water
February 24, 2018 - Treating sleep-disordered breathing may improve prognosis of heart failure patients
February 24, 2018 - More boys begin school a year late than girls, study finds
February 24, 2018 - Early life exposure to green space could have beneficial effects on cognitive function
February 24, 2018 - Joint Surgery: Aspirin Equals NOAC for Post-Acute VTE Prevention
February 23, 2018 - Scientists identify new marker of arthritis in mice
February 23, 2018 - Beetroot juice supplements may benefit patients with heart failure
February 23, 2018 - New study identifies novel molecular biomarkers of preeclampsia
February 23, 2018 - Researchers discover new link between gut bacteria and obesity
Experimental therapy may enhance recovery for stroke patients

Experimental therapy may enhance recovery for stroke patients

image_pdfDownload PDFimage_print

An experimental therapy being tested by University of Alberta scientists that targets the spinal cord may one day be key to spurring on enhanced recovery for stroke victims.

By injecting a drug called chondroitinase ABC (ChABC) into the spinal cord of rats 28 days after they suffered a stroke, researchers found they were able to enhance recovery by inducing amplified rewiring of circuits connecting the brain to the spinal cord. When they also combined the spinal therapy with rehabilitative training, recovery amplified further.

“This gives us real evidence that there are things we can do for people with a permanent physical disability–such as paralysis or having difficulty controlling movements–after a stroke,” said Ian Winship, an associate professor of psychiatry at the U of A. “There is hope that eventually we might have a therapy that can help somebody with a deficit that is really affecting their quality of life, even years after the stroke.”

“These are deficits that previously have been thought to be untreatable and people just learned to live with them,” added Anna Wiersma, lead author of the study and a recent PhD graduate at the U of A’s Neuroscience and Mental Health Institute. “The fact that these might not actually be untreatable and that we have an opportunity to help patients who are in the chronic stages of stroke is really exciting.”

Stroke is the most common cause of adult disability in Canada. Currently more than 400,000 Canadians are living with the effects of stroke. The typical path of recovery involves intensive rehabilitation therapy. In the first few weeks following a stroke, patients experience gains as the brain rewires itself, but they will eventually plateau and rarely regain full capacity–even with ongoing rehabilitation.

In the study, the scientists explored the impact of injecting ChABC into the spinal cord. The drug acts on components that surround the cells of the nervous system and prevent growth of new connections. It also removed the inhibition of growth, allowing for new connections between the unaffected motor areas in the brain and the spinal networks that control movement.

The researchers found that injecting ChABC a month after suffering a stroke and without rehabilitative training led to moderate improvements of sensorimotor deficits. When combining both spinal therapy and rehabilitative therapy, they found that their subjects recovered better and were able to perform some sensorimotor tasks at pre-stroke levels.

“The idea here is there is still something we can potentially do for people that would give them a second wave of recovery,” said Winship. “That’s pretty exciting because (rehabilitation efforts) have a ceiling effect. You can only achieve so much recovery. This drug could remove that ceiling.”

The researchers acknowledge there are barriers to overcome before the work could be tested and applied in humans. The major drawback is that injected ChABC only extends a small distance and acts for a finite period of time–both of which would be challenging in a human spinal cord, which is much larger than that of a rat. Time of recovery in a human is also much longer, meaning multiple injections would likely be needed, increasing the risk of infection or injury.

Winship and Wiersma speculate one solution may be to introduce the drug through another way than through injection. They believe using a viral vector could make cells genetically express ChABC instead of having it injected directly. The solution would allow for longer-lasting expression and greater spread within the spinal cord.

“The potential is there but at this point we need a lot more evidence that this is going to be something that is truly effective,” said Winship. “This approach is still a long way from the clinic, but this gives us real evidence that there are things we can do for people with permanent disability after a stroke.”

Source:

https://www.ualberta.ca/medicine/

Tagged with:

About author

Related Articles